48
Participants
Start Date
July 31, 2012
Primary Completion Date
April 30, 2015
Study Completion Date
October 31, 2015
PF804
45 mg p.o. daily and continuously (28-day treatment as one treatment cycle)
Severance hospital, Seoul
Yonsei University
OTHER